Postconcussion syndrome is as yet a poorly understood and controversial disorder. This article reviews a range of research considering the causes, symptoms, and possible interventions for postconcussion syndrome.
Definition
Postconcussion syndrome (PCS) is a potential consequence of mild traumatic brain injury (mTBI). mTBI is typically defined as a closed head injury, generally resulting from blunt force trauma to the head, with brief loss or disturbance of consciousness and/or posttraumatic amnesia (PTA). At presentation the Glasgow Coma Scale (GCS) score is 13-15. Results of computed tomography (CT) scans and neurological assessments are generally normal.
A number of descriptions of PCS have been given but there is as yet no universally agreed definition. The World Health Organisation has defined PCS as: A syndrome that occurs following head trauma (usually sufficiently severe to result in loss of consciousness) and including three or more of the following symptoms: Headache, Dizziness, Fatigue, Irritability, Difficulty in concentration and performing mental tasks, Impairment of memory, Insomnia, Reduced tolerance to stress, emotional excitement, or alcohol (World Health Organisation, 1992) .
The American Psychiatric Association (2000) has also produced a set of criteria for PCS (although they have termed it postconcussional disorder). They have defined it as a disorder for further study meaning that they believe that there is insufficient evidence to include it as an official disorder.
According to the APA, the patient with PCS has a history of head trauma that has caused significant cerebral concussion. In addition, neuropsychological testing or quantified cognitive assessment must show evidence of difficulty in attention or memory. Finally there must be three or more of the following symptoms: becoming fatigued easily; disordered sleep; headache; vertigo or dizziness; irritability or aggression; anxiety, depression or affective lability; changes in personality; apathy or lack of spontaneity. These symptoms must have their onset following a head injury, cause significant impairment in social or occupational functioning, and not be better accounted for by another condition (American Psychiatric Association, 2000) .
While ICD-10 and DSM-IV criteria are similar there are a number of differences, such as the requirement for evidence from neuropsychological testing. These differences in definition have important implications for the identification and study of PCS. For example, Boake et al. (2004; found a low level of agreement between ICD-10 and DSM-IV criteria for the diagnosis of PCS, with a prevalence rate of 11% when using DSM-IV criteria and of 64% when using ICD-10 criteria. This difference was mainly due to fewer patients meeting the DSM-IV criteria for cognitive deficit and clinical significance.
A further issue is that the definition of PCS contains nonspecific symptoms with considerable overlap with the nonbrain injured population, for example sleep disturbance. Many of these symptoms are also found in a range of psychiatric problems such as depression. For example 50-90% of people with depression also meet criteria for PCS (Iverson, 1996) .
Prevalence of PCS
Prevalence rates of PCS vary considerably between studies, possibly as a result of the aforementioned differences in diagnostic criteria. For example, Legome and Wu (2006) report that between 29 and 90% of head injured patients experience symptoms of PCS shortly after mTBI. While many develop symptoms of PCS, the vast majority recover within 3-6 months, with around 7-15% continuing to experience symptoms 1 year following injury (Hall et al., 2005) .
There are a number of methodological difficulties in determining the true prevalence of PCS. Firstly not everyone who has a mTBI seeks medical attention. mTBI has a reported annual prevalence of around 600 per 100,000, of whom around 75% seek medical attention (Sosin et al., 1996) . A further issue is the possibility of self-selection bias in mTBI research. McCullagh and Feinstein (2003) compared those who agree to participate in longitudinal mTBI research with those who do not. No premorbid differences were found between the groups. However, those in the participating group had higher scores on all measures of TBI severity and a higher rate of health care use. This suggests that the prevalence of PCS may be overestimated by some studies as it is the most severely affected who come to the attention of medical services and take part in studies.
Who will develop PCS?
Studies have examined a wide range of factors in attempting to predict who will develop PCS.
Organic factors mTBI frequently produces no obvious findings on CT or magnetic resonance imaging (MRI) scans. However, single-photon emission computed tomography (SPECT) scans have shown asymmetric and reduced regional cerebral blood flow (rCBF) for patients with a mTBI, particularly those who have reported posttraumatic head-aches (Gilkey et al., 1997) . Varney et al. (1995) found abnormal rCBF in a sub-group of PCS sufferers in the anterior and posterior areas.
Positron emission tomography (PET) scans have shown reduced rate of glucose utilisation in those with PCS (Solomon, 2001 ); Chen et al. (2003) found reduced rCBF during a memory task in patients with PCS. Umile et al. (2002) found abnormal PET and SPECT scan results in 90% of patients with PCS. Location of finding varied and did not correlate consistently with neuropsychological testing. Hoffman et al. (2002) compared those with PCS with a matched sample. They found that those with PCS had a significantly higher lesion load 1 year following injury and that these lesions were predominantly in the frontal and temporal regions. Macroscopic brain lesions which recover over the same period as PCS have been identified but have not been found to correlate well with PCS symptoms (Doezema et al., 1991; Levin et al., 1992 ).
S-100B
There has been some interest in the relationship between outcome following mTBI and levels of the protein s-100B. s-100B has been found to predict severity of brain injury (Pelinka et al., 2003; Savola et al., 2004) and is known as a good predictor of abnormal initial CT scan results (Bazarian et al., 2006) . However, its relationship to longer term outcomes is as yet unclear, with studies providing somewhat mixed results Levels of s-100B have been shown to predict overall outcome from traumatic brain injuries, with higher levels of s-100B relating to poorer overall outcomes (Pleines et al., 2001; Townend et al., 2002) . Stranjalis et al. (2004) found a significant correlation between return to work and elevated s-100B. Ingebrigtsen et al. (1999) found that patients with elevated s-100B levels showed a tendency towards impaired attention, memory and information processing speed at 3 months followup. However, other studies have found no such relationship (e.g., de Broussard et al., 2005) Studies examining the relationship between s-100B levels and PCS have also reported somewhat mixed findings. Stalnacke et al. (2005) found that s-100B was significantly associated with disability following MTBI, but not with PCS. Similar findings have been reported by Ingebrigtsen et al. (1995; and Bazarian et al. (2006) .
However, other studies have identified a positive relationship between s-100B levels and PCS symptoms (Ingebrigtsen et al., 2000; Savola and Hillbom, 2003) . Savola and Hillbom (2003) found that s-100B was a specific (93%) but not sensitive (27%) predictor of PCS symptoms.
Neuropsychological factors
Three areas of neuropsychological impairment have commonly been associated with PCS; memory, attention and information processing speed. Bazarian and Atabaki (2001) found that impaired working memory and verbal memory at initial assessment were associated with high risk of PCS at 1 month. An association between working memory and PCS has also been identified in a number of other studies (Newcombe et al., 1994; Cohen et al., 2001; Chen et al., 2003) . Impaired processing speed has also been frequently associated with PCS (Evans and Wilberger, 1999; Morris and Marshall, 2000) . For example, Cicerone and Azulay (2002) found that reduced processing speed was strongly predictive of a diagnosis of PCS.
Attentional difficulties have also been associated with PCS. Gronwall and Wrightson (1974) found that impaired selective attention correlated with PCS. Bohnen et al. (1992) found that patients with PCS performed less well on tests of selective and divided attention than non-PCS sufferers at 6 months post-mTBI. Chan (2002) reported a similar finding.
It is not clear whether neuropsychological impairment is a cause or a consequence of PCS. A number of authors have suggested explanations other than organic damage for neuropsychological impairment following mTBI. Depression and anxiety are both possible symptoms of PCS. PCS also shares many features with depression (Iverson, 2006) and is significantly correlated with PTSD (King, 1996) .
Both depression and PTSD are associated with cognitive impairment, such as memory (Beblo and Hermann, 2000; Yehuda et al., 2006; Jelinek et al., 2006) , attention (Cohen et al., 2001; PaeleckeHabermann et al., 2005; Veltmeyer et al., 2005; Stoddart et al., 2007) and information processing speed (Samuelson et al., 2006) . One study (Chamelian and Feinstein, 2006) found that the presence of depression following mild to moderate TBI was linked to a proportion of reported cognitive impairment, but did not explain all reported cognitive impairment. However, Chan (2002) found that PCS sufferers were impaired on measures of attention compared to controls and that this difference persisted where measures of emotional difficulties were controlled for.
This suggests that some cognitive impairment associated with PCS may be due to psychological difficulties, such as depression, it is also likely that organic factors are involved.
Psychological factors
It has long been believed that psychological factors play an important role in the development of PCS. Concurrent psychological difficulties have been found to predict PCS. King (1996) and King et al. (1999) found that score on the impact of events scale (a measure of posttraumatic stress) was the strongest predictor of PCS. Other predictors were depression and anxiety, posttraumatic amnesia and a measure of divided attention. Bryant and Harvey (1999) found that PCS was more evident in mTBI patients with PTSD and that PCS was significantly correlated with PTSD. McCauley et al. (2001) found that higher depression at 1 month was a risk factor for PCS.
Preexisting psychological conditions have also been associated with higher risk of developing PCS (Lishman, 1988; Ponsford et al., 2000; Legome and Wu, 2002) . For example, Mooney et al. (2005) found that a history of preinjury psychological trauma was associated with outcome following mTBI.
It has been suggested that psychological factors may predispose people to make attributions about PCS symptoms that are likely to exacerbate and maintain the condition. Whittaker et al. (2007) found that illness perceptions pertaining to beliefs about the consequences of an illness/injury has on physical social and psychological well being, predicted the development of PCS in 80% of patients. Stronger beliefs that a mTBI will have serious negative consequences were associated with PCS. Severity of symptoms at the time of injury was found to be predictive but not independently suggesting that it is the interpretation of symptoms that puts patients at risk of developing PCS.
A similar result was found by Mittenberg et al. (1992) . Miller and Mittenberg (1998) also found that the attribution of PCS symptoms to organic causes appears to be involved in the development of the disorder. Curran et al. (2000) found that posttraumatic brain injury emotional coping strategies characterised by wishful thinking and self-blame were associated with higher levels of depression and anxiety.
Malingering/compensation-seeking
There have been suggestions that at least some cases of PCS may be due to malingering and/or claims for compensation (Anderson et al., 2006) . Mittenberg et al. (2002) estimated base rates for probable malingering and exaggerated symptoms in people involved in legal cases such as personal injury and disability. They concluded that 39% of mild head injury patients involved in legal cases were malingering. Mickeviciene et al. (2004) compared people with a recent mTBI in Lithuania, where litigation is rare, with a comparable nonhead injured individuals. They found that while there was a significant increase in alcohol use and depression in the mTBI group, there were no differences in headaches, dizziness, or cognitive impairment. Reynolds et al. (2003) found that those seeking litigation following a MTBI took longer to return to work than those who were not. They also found that those who were seeking compensation through litigation generally took longer to return to work than those seeking or receiving compensation via administrative means, such as sick pay.
However, it has been found that more severe PCS is associated with compensation seeking rather than the other way round (Binder, 1993; Binder and Rohling 1996; King, 2003) . In addition, settlement does not generally lead to PCS symptom improvement (Gerard, 2000; King, 2003) Treatment of PCS While there are a range of medical strategies for the treatment of PCS symptoms (McIntosh, 1997) there are few outcome studies on their effectiveness (Mittenberg et al., 2001) . Selective serotonin reuptake inhibitors have been found to reduce PCS symptoms (Fann et al., 2000) as have benzodiazepines (Cytowick et al., 1987) .
A number of intervention studies for PCS have examined psychosocial strategies. Wade et al. (1997) found that specialist follow-up including neuropsychological assessment and treatment, cognitive behavioural therapy (CBT) or referral on to specialist services improved everyday functioning but not PCS symptoms in people with MTBI. However, in a second study (Wade et al., 1998) they found that a similar intervention led to both an improvement in daily functioning and a reduction in PCS symptoms. A difficulty in interpreting these findings is in determining which specific aspects of intervention were responsible for improvement. Ponsford et al. (2002) compared standard emergency department treatment to an intervention consisting of neuropsychological assessment and provision of an information booklet 5-7 days postinjury. They found that those in the intervention group reported fewer PCS symptoms at a 3 month follow-up. Mittenberg et al. (1996) compared patients with PCS who received CBT with matched controls. Those in the CBT group experienced fewer symptoms, less severe symptoms and a shorter symptom duration Miller and Mittenberg (1998) also found that brief psychological interventions are effective in reducing PCS symptoms. Mittenberg et al. (2001) found that psychological interventions where PCS symptoms are reattributed to benign causes are effective in reducing PCS.
Conclusion
PCS continues to be a controversial and poorly understood condition with a range of studies examining different possible predictors but no comprehensive explanatory model. However, the available evidence does allow for some conclusions to be made. Evidence from imaging studies indicates that there may be an organic underpinning to PCS. There is also evidence suggesting that psychological factors are involved. Those with abnormal PET and SPECT scans seem to be at greater risk as are those with premorbid and/or concurrent psychological problems. There is also evidence that cognitive impairment at the time of injury is associated with poor outcome. There is some recent evidence that the manner in which a person views their injury is important in terms of developing PCS as are the types of attributions they make about subsequent symptoms. In terms of treatment there is some evidence for the efficacy of psychotropic medication and psychosocial approaches with the provision of education about MTBI and PCS at time of injury and possibly CBT for more chronic cases.
